Related Experiment Video
Updated: Mar 14, 2026

05:44
Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
Published on: June 10, 2025
1.4K
Borderline Tuberculoid Leprosy Associated with Histoid Leprosy
1Department of Dermatology, SVS Medical College, Yenugonda, Mahbubnagar, Telangana, India.
Indian Journal of Dermatology
|October 1, 2016
Summary
This rare case highlights borderline tuberculoid (BT) leprosy coexisting with histoid leprosy (HL) in one patient. Histopathology confirmed both distinct leprosy forms in a single immune-competent individual.
Area of Science:
- Dermatology
- Immunology
- Infectious Diseases
Background:
- Leprosy presents with diverse clinical and immunological manifestations.
- Coexistence of distinct leprosy forms within a single patient is exceptionally rare.
- Histoid leprosy (HL) and borderline tuberculoid (BT) leprosy represent different points on the leprosy spectrum.
Purpose of the Study:
- To report an extremely rare case of coexisting borderline tuberculoid (BT) leprosy and histoid leprosy (HL) in an immunocompetent individual.
- To describe the clinical presentation and histopathological findings of this unusual leprosy association.
Main Methods:
- A case study approach was employed.
- Clinical examination of skin lesions was performed.
- Histopathological examination of biopsies from different lesions was conducted to differentiate leprosy types.
Main Results:
- The patient, previously diagnosed with BT leprosy, presented with new papules and nodules.
- Histopathological analysis revealed features consistent with BT leprosy in one biopsy.
- Simultaneously, another biopsy showed histopathological characteristics of HL.
Conclusions:
- This case demonstrates the rare coexistence of BT leprosy and HL in an immunocompetent male.
- The findings underscore the complex immunological spectrum of leprosy.
- Such rare presentations necessitate thorough histopathological evaluation for accurate diagnosis and management.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis III
1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
Pulmonary Tuberculosis II
1.9K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K
Pulmonary Tuberculosis IV
609
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
609
Pulmonary Tuberculosis V
728
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
728
Pulmonary Tuberculosis I
1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
116
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
116

